Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 13
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase I/II Chemotherapy with L-Alanosine for Refractory Pediatric Solid Tumors and Relapsed Pediatric Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
under 21
NCI
POG-8155
2.
Phase II Evaluation of L-Alanosine in Acute Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 16
NCI
SWOG-8051
Last Modified:
4/26/2007
3.
Phase II Chemotherapy with Single Agents Selected by Soft Agar Colony Sensitivity Studies for Advanced Renal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAYO-805002
NCCTG-805002, NCI-W81-0587
4.
Phase II Chemotherapy with PALA/L-Alanosine for Residual, Recurrent, or Metastatic Colorectal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAYO-814603
5.
Phase II Single-Agent Chemotherapy in Patients with Advanced Ovarian Carcinoma Using Agents Selected by Soft Agar Colony Sensitivity Studies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAYO-816101
Last Modified:
4/26/2007
6.
Phase II Master Protocol for Chemotherapy for Recurrent or Stage IV Renal Cell Carcinoma --- VBL vs L-Alanosine vs Acivicin vs CTX vs Misonidazole vs Aminothiadiazole
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-1882
7.
Phase II Chemotherapy with L-Alanosine for Patients with Metastatic Carcinoma of the Breast Refractory to Standard Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
NCI
SWOG-8304
Last Modified:
12/6/2007
8.
Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
NCCTG-837051
NCCTG-83-70-51
9.
Phase II Chemotherapy with L-Alanosine for Advanced Large Bowel Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAYO-804601
10.
Phase II Chemotherapy with L-Alanosine for Advanced Malignant Melanoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
no age specified
MAYO-807003
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute